94 related articles for article (PubMed ID: 25636360)
1. [Informing the family: emotions and attitudes of oncogenetic counselees for familial breast/ovarian and/or colon cancer risk].
Kwiatkowski F; Laquet C; Dessenne P; Bignon YJ
Bull Cancer; 2015 Feb; 102(2):162-73. PubMed ID: 25636360
[TBL] [Abstract][Full Text] [Related]
2. Permanence of the information given during oncogenetic counseling to persons at familial risk of breast/ovarian and/or colon cancer.
Kwiatkowski F; Dessenne P; Laquet C; Petit MF; Bignon YJ
Eur J Hum Genet; 2012 Feb; 20(2):141-7. PubMed ID: 21934710
[TBL] [Abstract][Full Text] [Related]
3. BRACAVENIR - impact of a psychoeducational intervention on expectations and coping in young women (aged 18-30 years) exposed to a high familial breast/ovarian cancer risk: study protocol for a randomized controlled trial.
Kwiatkowski F; Dessenne P; Laquet C; Daures JP; Gay-Bellile M; Bignon YJ
Trials; 2016 Oct; 17(1):509. PubMed ID: 27769293
[TBL] [Abstract][Full Text] [Related]
4. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
[TBL] [Abstract][Full Text] [Related]
5. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
[TBL] [Abstract][Full Text] [Related]
6. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
7. Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment.
Vos J; Menko FH; Oosterwijk JC; van Asperen CJ; Stiggelbout AM; Tibben A
Psychooncology; 2013 May; 22(5):1167-76. PubMed ID: 22777929
[TBL] [Abstract][Full Text] [Related]
8. [Information spreading about hereditary carriage of a BRCA1/2 mutation and ovarian cancer and rate of consultation of the concerned relatives].
Christophe V; Leroy T; Adenis C; Reich M; Vennin P
Bull Cancer; 2008 Apr; 95(4):395-402. PubMed ID: 18495568
[TBL] [Abstract][Full Text] [Related]
9. Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.
de Geus E; Aalfs CM; Verdam MG; de Haes HC; Smets EM
Trials; 2014 Mar; 15():86. PubMed ID: 24649895
[TBL] [Abstract][Full Text] [Related]
10. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
[TBL] [Abstract][Full Text] [Related]
11. We are talking, but are they listening? Communication patterns in families with a history of breast/ovarian cancer (HBOC).
Kenen R; Arden-Jones A; Eeles R
Psychooncology; 2004 May; 13(5):335-45. PubMed ID: 15133774
[TBL] [Abstract][Full Text] [Related]
12. Distress and family functioning in oncogenetic counselling for hereditary and familial breast and/or ovarian cancers.
Condello C; Gesuita R; Pensabene M; Spagnoletti I; Capuano I; Baldi C; Carle F; Contegiacomo A
J Genet Couns; 2007 Oct; 16(5):625-34. PubMed ID: 17701329
[TBL] [Abstract][Full Text] [Related]
13. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.
Bonadona V; Saltel P; Desseigne F; Mignotte H; Saurin JC; Wang Q; Sinilnikova O; Giraud S; Freyer G; Plauchu H; Puisieux A; Lasset C
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):97-104. PubMed ID: 11815406
[TBL] [Abstract][Full Text] [Related]
14. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
[TBL] [Abstract][Full Text] [Related]
15. Does enhanced information at cancer genetic counseling improve counselees' knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives?--a randomized study.
Roshanai AH; Rosenquist R; Lampic C; Nordin K
Acta Oncol; 2009; 48(7):999-1009. PubMed ID: 19636983
[TBL] [Abstract][Full Text] [Related]
16. Communication and decision-making about seeking inherited cancer risk information: findings from female survivor-relative focus groups.
Mellon S; Berry-Bobovski L; Gold R; Levin N; Tainsky MA
Psychooncology; 2006 Mar; 15(3):193-208. PubMed ID: 16100704
[TBL] [Abstract][Full Text] [Related]
17. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history.
Nelson CL; Sellers TA; Rich SS; Potter JD; McGovern PG; Kushi LH
Genet Epidemiol; 1993; 10(4):235-44. PubMed ID: 8224804
[TBL] [Abstract][Full Text] [Related]
18. Exploring family relationships in cancer risk counseling using the genogram.
Daly M; Farmer J; Harrop-Stein C; Montgomery S; Itzen M; Costalas JW; Rogatko A; Miller S; Balshem A; Gillespie D
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):393-8. PubMed ID: 10207645
[TBL] [Abstract][Full Text] [Related]
19. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.
Lynch HT; Watson P; Conway TA; Lynch JF; Slominski-Caster SM; Narod SA; Feunteun J; Lenoir G
Arch Intern Med; 1993 Sep; 153(17):1979-87. PubMed ID: 8357282
[TBL] [Abstract][Full Text] [Related]
20. Healthy women from suspected hereditary breast and ovarian cancer families: the significant others in their lives.
Kenen R; Arden-Jones A; Eeles R
Eur J Cancer Care (Engl); 2004 May; 13(2):169-79. PubMed ID: 15115473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
